|
TCP11L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.432200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.511400E-01 |
| Normal-vs-Stage2 |
7.363000E-01 |
| Normal-vs-Stage3 |
4.930000E-01 |
| Normal-vs-Stage4 |
4.900000E-01 |
| Stage1-vs-Stage2 |
7.154400E-01 |
| Stage1-vs-Stage3 |
6.494200E-01 |
| Stage1-vs-Stage4 |
6.115600E-01 |
| Stage2-vs-Stage3 |
4.474200E-01 |
| Stage2-vs-Stage4 |
4.249600E-01 |
| Stage3-vs-Stage4 |
8.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.447800E-01 |
| Normal-vs-AfricanAmerican |
5.469800E-01 |
| Normal-vs-Asian |
1.476460E-03 |
| Caucasian-vs-AfricanAmerican |
5.984200E-01 |
| Caucasian-vs-Asian |
1.653540E-02 |
| AfricanAmerican-vs-Asian |
7.136000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.057400E-01 |
| Normal-vs-Female |
1.917450E-01 |
| Male-vs-Female |
1.257230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.264600E-01 |
| Normal-vs-Extreme_Weight |
1.401760E-01 |
| Normal-vs-Obese |
2.737800E-01 |
| Normal-vs-Extreme_Obese |
5.877800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.641000E-01 |
| Normal_Weight-vs-Obese |
2.723400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.193600E-01 |
| Extreme_Weight-vs-Obese |
3.834000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.436800E-01 |
| Obese-vs-Extreme_Obese |
3.326600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.265400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.726350E-01 |
| Normal-vs-Age(61-80Yrs) |
4.022600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.015600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.419800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.394000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.724500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.300300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.036200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.844300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.102400E-01 |
| Normal-VS-Type2 PRCC |
3.991900E-02 |
| Normal-VS-KIRP CIMP |
3.050400E-01 |
| Normal-VS-Unclassified PRCC |
1.223370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.937700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.756800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.319960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.903800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.164200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.219000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.522500E-02 |
| Normal-vs-N1 |
6.046200E-01 |
| Normal-vs-N2 |
6.513200E-01 |
| N0-vs-N1 |
5.604300E-02 |
| N0-vs-N2 |
8.477000E-01 |
| N1-vs-N2 |
5.466800E-01 |
|
|
